Gray Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$734K Buy
4,130
+4
+0.1% +$735 0.28% 53
2024
Q3
$815K Buy
4,126
+146
+4% +$27.2K 0.32% 51
2024
Q2
$683K Buy
3,980
+63
+2% +$10.4K 0.29% 54
2024
Q1
$713K Buy
3,917
+223
+6% +$38.4K 0.32% 54
2023
Q4
$573K Sell
3,694
-913
-20% -$133K 0.28% 60
2023
Q3
$687K Buy
4,607
+23
+0.5% +$3.38K 0.35% 55
2023
Q2
$618K Buy
4,584
+173
+4% +$25.4K 0.31% 61
2023
Q1
$703K Buy
4,411
+181
+4% +$27.7K 0.38% 56
2022
Q4
$684K Sell
4,230
-6
-0.1% -$920 0.4% 55
2022
Q3
$568K Buy
4,236
+40
+1% +$5.74K 0.36% 56
2022
Q2
$643K Sell
4,196
-6
-0.1% -$917 0.39% 50
2022
Q1
$681K Buy
4,202
+120
+3% +$17.4K 0.35% 54
2021
Q4
$553K Buy
4,082
+158
+4% +$18.7K 0.28% 62
2021
Q3
$423K Sell
3,924
-462
-11% -$52.8K 0.24% 69
2021
Q2
$494K Sell
4,386
-132
-3% -$14.9K 0.28% 64
2021
Q1
$489K Buy
4,518
+1,414
+46% +$151K 0.31% 60
2020
Q4
$334K Sell
3,104
-474
-13% -$45.5K 0.23% 72
2020
Q3
$316K Buy
3,578
+1,128
+46% +$106K 0.25% 67
2020
Q2
$238K Buy
+2,450
New +$216K 0.21% 80

Other funds holding ABBV

Gray Wealth Management's ABBV Position: Q4 2024 in Review

Gray Wealth Management increased its AbbVie (ABBV) stake by 0.1% in Q4 2024, buying an estimated $735 and bringing the position to 4,130 shares worth $734K. The position accounts for 0.28% of the portfolio, ranked #53.

Gray Wealth Management first reported a position in ABBV in Q2 2020 and has held it in 19 quarters since. The position peaked at $815K in Q3 2024. 3,744 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.

  • Gray Wealth Management held 4,130 shares of AbbVie worth $734K as of Q4 2024.
  • Gray Wealth Management bought 4 AbbVie shares in Q4 2024, an estimated $735.
  • AbbVie made up 0.28% of Gray Wealth Management's portfolio in Q4 2024, its #53 holding.
  • Gray Wealth Management first reported a position in AbbVie in Q2 2020 and has held it in 19 quarters since.
  • Gray Wealth Management's AbbVie position peaked at $815K in Q3 2024.
  • 3,744 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.

Based on Gray Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.